Mutations that cause esophageal adenocarcinoma (OAC) have been mapped in unprecedented detail — unveiling that more than half could be
Mapping esophageal cancer genes leads to new drug targets
More accurate leukemia diagnosis expected as researchers refine leukemia classification
Like cartographers completing a map, investigators have identified multiple new subtypes of the most common childhood cancer — research that
Epigenetic treatments could trigger the development of aggressive tumors
Cancer develops as a result of the accumulation of mutations in our cells. These mutations are not distributed evenly in
Anti-Malaria drugs have shown promise in treating cancer: What drugs known as chloroquines are targeting
Anti-malaria drugs known as chloroquines have been repurposed to treat cancer for decades, but until now no one knew exactly
Unique type of skeletal stem cells found in ‘resting zone’ are actually hard at work
Skeletal stem cells are valuable because it’s thought they can heal many types of bone injury, but they’re difficult to
New way to determine whether metastatic cancer cells in breast cancer patients are dormant or soon to turn deadly
For the first time ever, Mount Sinai researchers have identified a protein as a marker that can indicate whether a
Small molecule plays big role in weaker bones as we age
With age, expression of a small molecule that can silence others goes way up while a key signaling molecule that
More breast cancer patients can safely forgo chemotherapy: Study
A 21-gene test performed on tumors could enable most patients with the most common type of early breast cancer to
Tumor cells evade death through in extremis DNA repair: A study on breast cancer conducted at IRB Barcelona identifies the key role of p38 in safeguarding tumor cells against the excessive accumulation of DNA damage, which would otherwise cause cell death
Greater knowledge of the mechanisms that contribute to the survival of tumour cells is key to vanquishing them. The study
Early exposure to microbes may protect against childhood leukemia
In a paper now published in the journal Nature Reviews Cancer, Prof. Mel Greaves — from the Institute of Cancer